ARTICLE | Clinical News
Fycompa perampanel regulatory update
October 28, 2013 7:00 AM UTC
Eisai said Israel approved Fycompa perampanel as an adjunctive treatment for partial onset seizures, with or without secondary generalization, in patients with epilepsy ages >=12 years. Eisai said the...